Epidemiology of viral hepatitis and hepatocellular carcinoma.

Most cases of hepatocellular carcinoma (HCC) are associated with cirrhosis related to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Changes in the time trends of HCC and most variations in its age-, sex-, and race-specific rates among different regions are likely to be related to differences in hepatitis viruses that are most prevalent in a population, the timing of their spread, and the ages of the individuals the viruses infect. Environmental, host genetic, and viral factors can affect the risk of HCC in individuals with HBV or HCV infection. This review summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States.

[1]  J. Kaldor,et al.  Estimating progression to cirrhosis in chronic hepatitis C virus infection , 2001, Hepatology.

[2]  H. El‐Serag,et al.  Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. , 2008, Journal of hepatology.

[3]  Ding‐Shinn Chen,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level , 2007 .

[4]  Wei Wu,et al.  Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[5]  K. Chayama,et al.  Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. , 1998, Journal of hepatology.

[6]  S. Mano,et al.  Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. , 2006, Gastroenterology.

[7]  Angelique Zeringue,et al.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. , 2011, Gastroenterology.

[8]  T. Therneau,et al.  Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  S. Porru,et al.  Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.

[10]  P Boffetta,et al.  A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.

[11]  P. Boffetta,et al.  Interaction between Cigarette Smoking and Hepatitis B and C Virus Infection on the Risk of Liver Cancer: A Meta-analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[12]  Ai-Jun Li,et al.  Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. , 2010, Journal of hepatology.

[13]  S. Bird,et al.  Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  C. J. Chen,et al.  Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. , 2000, Journal of the National Cancer Institute.

[15]  Chun-Jen Liu,et al.  Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. , 2011, Carcinogenesis.

[16]  P. Pontisso,et al.  HCV-associated liver cancer without cirrhosis , 1995, The Lancet.

[17]  Ding-Shinn Chen,et al.  Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. , 2006, The Journal of infectious diseases.

[18]  U. Cnrs.  Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections , 2006 .

[19]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  Chien-Jen Chen,et al.  Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Hoofnagle,et al.  Increased caffeine consumption is associated with reduced hepatic fibrosis , 2010, Hepatology.

[22]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[23]  M. Woodward,et al.  Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. , 2009, Archives of internal medicine.

[24]  S. Taylor-Robinson,et al.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. , 2008, World Journal of Gastroenterology.

[25]  M. Lai,et al.  Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection , 2006, Hepatology.

[26]  Mei-Hwei Chang,et al.  Hepatitis B virus and cancer prevention. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[27]  P. Simmonds,et al.  Association between chronic hepatitis C infection and hepatocellular carcinoma , 1995, The Lancet.

[28]  L. Lai,et al.  Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy. , 1997, The Western journal of medicine.

[29]  C. la Vecchia,et al.  Coffee drinking and hepatocellular carcinoma risk: A meta‐analysis , 2007, Hepatology.

[30]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  G. Fattovich,et al.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.

[32]  X. Shen,et al.  Tumour necrosis factor 308 polymorphisms and hepatocellular carcinoma risk: a meta-analysis. , 2010, Hepato-gastroenterology.

[33]  J. Stockman.  Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women , 2006 .

[34]  H. El‐Serag,et al.  The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans , 2001, American Journal of Gastroenterology.

[35]  Ding‐Shinn Chen,et al.  Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.

[36]  C. la Vecchia,et al.  Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004 , 2008, Hepatology.

[37]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[38]  H. El‐Serag,et al.  Higher serum testosterone is associated with increased risk of advanced hepatitis C–related liver disease in males , 2012, Hepatology.

[39]  Zhiwen Liu,et al.  Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis , 2012, Diabetes/metabolism research and reviews.

[40]  Thomas K. Hazlet,et al.  Global Epidemiology of Hepatitis B Virus , 2004, Journal of clinical gastroenterology.

[41]  William M. Lee,et al.  Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C , 2009, Hepatology.

[42]  Y. Liu,et al.  Tumour Necrosis Factor-α Polymorphisms and Hepatocellular Carcinoma: A Meta-analysis , 2010 .

[43]  B. Henderson,et al.  A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China , 1995, International journal of cancer.

[44]  K. Tsoi,et al.  Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma , 2008, Alimentary pharmacology & therapeutics.

[45]  I. Hung,et al.  Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma , 2011, Hepatology.

[46]  Shiyuan Liu,et al.  A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.

[47]  Manal M. Hassan,et al.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. , 2009, Journal of hepatology.

[48]  Chien-Jen Chen,et al.  Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. , 2010, Gastroenterology.

[49]  J. Miller,et al.  Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. , 1972, Cancer research.

[50]  Y. Jeng,et al.  Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. , 2004, Gastroenterology.

[51]  H. El‐Serag,et al.  Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[52]  K. Yoo,et al.  Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysis , 2011, International journal of cancer.

[53]  H. El‐Serag,et al.  The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? , 2003, American Journal of Gastroenterology.

[54]  A. Hall,et al.  The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea–Conakry, West Africa , 2002, Journal of gastroenterology and hepatology.

[55]  D. Harnois,et al.  Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .

[56]  M. Mondelli,et al.  Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. , 2009, Journal of hepatology.

[57]  M. Mizokami,et al.  Molecular Evolution of Hepatitis Viruses , 1999, Intervirology.

[58]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[59]  J. Samet,et al.  Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. , 2004, Journal of the National Cancer Institute.

[60]  J. Wands,et al.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.

[61]  B. McMahon,et al.  Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. , 1990, Archives of internal medicine.

[62]  H. El‐Serag,et al.  Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. , 2008, American journal of epidemiology.

[63]  Pei-Jer Chen,et al.  Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones , 2010, Oncology.

[64]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[65]  R. Feng,et al.  The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis , 2011, Journal of Cancer Research and Clinical Oncology.

[66]  S. Larsson,et al.  Coffee consumption and risk of liver cancer: a meta-analysis. , 2007, Gastroenterology.

[67]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[68]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[69]  Oliver N Keene,et al.  Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.

[70]  Y. Liu,et al.  Tumour necrosis factor-alpha polymorphisms and hepatocellular carcinoma: a meta-analysis. , 2010, The Journal of international medical research.

[71]  Chien-Jen Chen,et al.  Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  Chien-Jen Chen,et al.  Hepatitis B virus DNA levels and outcomes in chronic hepatitis B , 2009, Hepatology.

[73]  Fei Liu,et al.  XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta‐analysis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[74]  H. Margolis,et al.  Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. , 1998, The Journal of infectious diseases.